C. Gengler and L. Guillou, Solitary fibrous tumour and haemangiopericytoma: evolution of a concept, Histopathology, vol.447, issue.1, pp.63-74, 2006.
DOI : 10.1097/00000478-199711000-00010

L. Guillou, J. Fletcher, and C. Fletcher, Mandahl: Extra pleural solitary fibrous tumour and haemangiopericytoma in WHO Classification of Tumours. In Pathology and Genetics of Tumours of Soft Tissue and Bone, pp.86-90

C. Giannini, E. Rushing, J. Hainfelier, H. Ohgaki, O. Wiestler et al., Hemangiopericytoma in the WHO classification of Tumours of the Central Nervous System, pp.178-180

W. Paulus, B. Scheithauer, A. Perry, H. Ohgaki, O. Wiestler et al., Mesenchymal non-meningothelial tumors In the WHO classification of Tumours of the Central Nervous System, pp.173-177

C. Bouvier, P. Metellus, A. De-paula, A. Vasiljevic, A. Jouvet et al., Solitary Fibrous Tumors and Hemangiopericytomas of the Meninges: Overlapping Pathological Features and Common Prognostic Factors Suggest the Same Spectrum of Tumors, Brain Pathology, vol.34, issue.4, pp.511-521, 2012.
DOI : 10.1111/j.1750-3639.2011.00552.x

M. Amary, F. Berisha, B. Fdel, C. Herbert, A. James et al., Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma, Modern Pathology, vol.124, issue.4, pp.482-496, 2007.
DOI : 10.1038/labinvest.3780455

Y. Lu, S. Birdsall, B. Summersgill, D. Smedley, P. Osin et al., Dual colour fluorescencein situ hybridization to paraffin-embedded samples to deduce the presence of the der(X)t(X;18)(p11.2;q11.2) and involvement of either theSSX1 orSSX2 gene: a diagnostic and prognostic aid for synovial sarcoma, The Journal of Pathology, vol.11, issue.4, pp.490-496, 1999.
DOI : 10.1002/(SICI)1096-9896(199903)187:4<490::AID-PATH274>3.0.CO;2-X

A. Sandberg and J. Bridge, Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma, Cancer Genetics and Cytogenetics, vol.133, issue.1, pp.1-23, 2002.
DOI : 10.1016/S0165-4608(01)00626-4

S. Aiba, N. Tabata, H. Ishii, H. Ootani, and H. Tagami, Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34, British Journal of Dermatology, vol.96, issue.2
DOI : 10.1007/BF01600148

C. Civin, L. Strauss, C. Brovall, M. Fackler, J. Schwartz et al., Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells, J Immunol, vol.133, pp.157-165, 1984.

P. Cohen, R. Rapini, and A. Farhood, Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors, Journal of Cutaneous Pathology, vol.17, issue.1, pp.15-20, 1993.
DOI : 10.1001/archderm.110.6.874

L. Fina, H. Molgaard, D. Robertson, N. Bradley, P. Monaghan et al., Expression of the CD34 gene in vascular endothelial cells, Blood, vol.75, pp.2417-2426, 1990.

G. Lin, E. Finger, and J. Gutierrez-ramos, Expression of CD34 in endothelial cells, hematopoietic progenitors and nervous cells in fetal and adult mouse tissues, European Journal of Immunology, vol.159, issue.6, pp.1508-1516, 1995.
DOI : 10.1002/eji.1830250606

M. Miettinen, A. Lindenmayer, and A. Chaubal, Endothelial cell markers CD31, CD34, and BNH9 antibody to H-and Y-antigens?evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor, Mod Pathol, vol.7, pp.82-90, 1994.

B. Nickoloff, The Human Progenitor Cell Antigen (CD34) Is Localized on Endothelial Cells, Dermal Dendritic Cells, and Perifollicular Cells in Formalin-Fixed Normal Skin, and on Proliferating Endothelial Cells and Stromal Spindle-Shaped Cells in Kaposi's Sarcoma, Archives of Dermatology, vol.127, issue.4, pp.523-529, 1991.
DOI : 10.1001/archderm.1991.04510010091009

S. Traweek, P. Kandalaft, P. Mehta, and H. Battifora, The Human Hematopoietic Progenitor Cell Antigen (CD 3 4) in Vascular Neoplasia, American Journal of Clinical Pathology, vol.96, issue.1, pp.25-31, 1991.
DOI : 10.1093/ajcp/96.1.25

A. Perry, B. Scheithauer, and A. Nascimento, The Immunophenotypic Spectrum of Meningeal Hemangiopericytoma: A Comparison With Fibrous Meningioma and Solitary Fibrous Tumor of Meninges, The American Journal of Surgical Pathology, vol.21, issue.11, pp.1354-1360, 1997.
DOI : 10.1097/00000478-199711000-00010

M. Van-de-rijn, C. Lombard, and R. Rouse, Expression of CD34 by Solitary Fibrous Tumors of the Pleura, Mediastinum, and Lung, The American Journal of Surgical Pathology, vol.18, issue.8, pp.814-820, 1994.
DOI : 10.1097/00000478-199408000-00008

W. Westra, W. Gerald, and J. Rosai, Solitary Fibrous Tumor Consistent CD34 Immunoreactivity and Occurrence in the Orbit, The American Journal of Surgical Pathology, vol.18, issue.10, pp.992-998, 1994.
DOI : 10.1097/00000478-199410000-00003

T. Hasegawa, Y. Matsuno, T. Shimoda, S. Hirohashi, T. Hirose et al., Frequent Expression of bcl-2 Protein in Solitary Fibrous Tumors, Japanese Journal of Clinical Oncology, vol.28, issue.2, pp.86-91, 1998.
DOI : 10.1093/jjco/28.2.86

M. Hajdu, S. Singer, R. Maki, G. Schwartz, and M. Keohan, IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting, The Journal of Pathology, vol.168, issue.suppl, pp.300-307, 2010.
DOI : 10.1002/path.2715

R. West, D. Nuyten, S. Subramanian, T. Nielsen, C. Corless et al., Determination of Stromal Signatures in Breast Carcinoma, PLoS Biology, vol.23, issue.6, p.187, 2005.
DOI : 10.1371/journal.pbio.0030187.st004

P. Marcato, C. Dean, C. Giacomantonio, and P. Lee, Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform, Cell Cycle, vol.10, issue.9, pp.1378-1384, 2011.
DOI : 10.4161/cc.10.9.15486

L. Armstrong, M. Stojkovic, I. Dimmick, S. Ahmad, P. Stojkovic et al., Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehydedehydrogenase activity, Stem Cells, issue.7, pp.221142-1151, 2004.

J. Chute, G. Muramoto, J. Whitesides, M. Colvin, R. Safi et al., Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells, Proceedings of the National Academy of Sciences, vol.103, issue.31, pp.11707-11712, 2006.
DOI : 10.1073/pnas.0603806103

K. Honoki, H. Fujii, A. Kubo, A. Kido, T. Mori et al., Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance, Oncology Reports, vol.24, issue.2, pp.501-505, 2010.
DOI : 10.3892/or_00000885

L. Wang, P. Park, H. Zhang, L. Marca, F. et al., Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity, International Journal of Cancer, vol.110, issue.Suppl 1, pp.294-303, 2011.
DOI : 10.1002/ijc.25331

S. Ricardo, A. Vieira, R. Gerhard, D. Leitao, R. Pinto et al., Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype, Journal of Clinical Pathology, vol.64, issue.11, pp.937-946, 2011.
DOI : 10.1136/jcp.2011.090456

URL : http://jcp.bmj.com/cgi/content/short/64/11/937

N. Sladek, R. Kollander, L. Sreerama, and D. Kiang, Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorinebased cancer chemotherapeutic regimens, Cancer Chemother Pharmacol, vol.49, pp.309-321, 2002.

L. Sreerama and N. Sládek, Primary breast tumor levels of suspected molecular determinants of cellular sensitivity to cyclophosphamide, ifosfamide, and certain other anticancer agents as predictors of paired metastatic tumor levels of these determinants. Rational individualization of cancer chemotherapeutic regimens, Cancer Chemother Pharmacol, issue.3, pp.47255-262, 2001.

G. Rekha, L. Sreerama, and N. Sladek, Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase, Biochemical Pharmacology, vol.48, issue.10, pp.1943-1952, 1994.
DOI : 10.1016/0006-2952(94)90593-2

H. Friedman, O. Colvin, S. Kaufmann, S. Ludeman, N. Bullock et al., Cyclophosphamide resistance in medulloblastoma, Cancer Res, vol.52, pp.5373-5378, 1992.

M. Magni, S. Shammah, R. Schiró, W. Mellado, R. Dalla-favera et al., Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer, Blood, vol.87, issue.3, pp.1097-1103, 1996.

P. Hingorani, W. Zhang, S. Piperdi, L. Pressman, J. Lin et al., Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma, Cancer Chemotherapy and Pharmacology, vol.24, issue.4, pp.733-740, 2009.
DOI : 10.1007/s00280-008-0922-4

S. Marchitti, C. Brocker, D. Stagos, and V. Vasiliou, Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily, Expert Opinion on Drug Metabolism & Toxicology, vol.182, issue.6, pp.697-720, 2008.
DOI : 10.1016/j.brainres.2006.09.081

J. Chmielecki, A. Crago, M. Rosenberg, O. Connor, R. Walker et al., Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors, Nature Genetics, vol.2, issue.2, pp.131-132, 2013.
DOI : 10.1038/nature11154

D. Robinson, M. Wu, S. Sundaram, X. Cao, R. Lonigro et al., Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing, Nature Genetics, vol.13, issue.2, pp.180-185, 2013.
DOI : 10.1016/j.ccr.2010.03.018

F. Bertucci, P. Finetti, N. Cervera, E. Charafe-jauffret, E. Mamessier et al., Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers, Cancer Research, vol.66, issue.9, pp.664636-4644, 2006.
DOI : 10.1158/0008-5472.CAN-06-0031

E. Claus, P. Park, R. Carroll, J. Chan, and P. Black, Specific Genes Expressed in Association with Progesterone Receptors in Meningioma, Cancer Research, vol.68, issue.1, pp.314-322, 2008.
DOI : 10.1158/0008-5472.CAN-07-1796

Y. Lee, J. Liu, S. Patel, T. Cloughesy, A. Lai et al., Genomic Landscape of Meningiomas, Brain Pathology, vol.11, issue.4, pp.751-762, 2010.
DOI : 10.1111/j.1750-3639.2009.00356.x

R. Nakayama, T. Nemoto, H. Takahashi, T. Ohta, A. Kawai et al., Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma, Modern Pathology, vol.81, issue.7, pp.749-759, 2007.
DOI : 10.1038/ng850

K. Detwiller, N. Fernando, N. Segal, S. Ryeom, D. Amore et al., Analysis of Hypoxia-Related Gene Expression in Sarcomas and Effect of Hypoxia on RNA Interference of Vascular Endothelial Cell Growth Factor A, Cancer Research, vol.65, issue.13, pp.655881-5889, 2005.
DOI : 10.1158/0008-5472.CAN-04-4078

R. Irizarry, B. Hobbs, C. F. Beazer-barclay, Y. Antonellis, and K. , Exploration, normalization, and summaries of high density oligonucleotide array probe level data, Biostatistics, vol.4, issue.2, pp.249-264, 2003.
DOI : 10.1093/biostatistics/4.2.249

E. Eisenberg and E. Levanon, Human housekeeping genes are compact, Trends in Genetics, vol.19, issue.7, pp.362-365, 2003.
DOI : 10.1016/S0168-9525(03)00140-9

URL : http://arxiv.org/abs/q-bio/0309020

M. Benito, J. Parker, Q. Du, J. Wu, D. Xiang et al., Adjustment of systematic microarray data biases, Bioinformatics, vol.20, issue.1, pp.105-114, 2004.
DOI : 10.1093/bioinformatics/btg385

S. Salas, P. Jézéquel, L. Campion, J. Deville, F. Chibon et al., Molecular characterization of the response to chemotherapy in conventional osteosarcomas: Predictive value of HSD17B10 and IFITM2, International Journal of Cancer, vol.38, issue.4, pp.851-860, 2009.
DOI : 10.1002/ijc.24457

N. Hawass, Comparing the sensitivities and specificities of two diagnostic procedures performed on the same group of patients., The British Journal of Radiology, vol.70, issue.832, pp.360-366, 1997.
DOI : 10.1259/bjr.70.832.9166071